Citadel Advisors - LOGICBIO THERAPEUTICS INC ownership

LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 47 filers reported holding LOGICBIO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of LOGICBIO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$32,000
+300.0%
115,925
+439.2%
0.00%
Q2 2022$8,000
-38.5%
21,500
+14.4%
0.00%
Q1 2022$13,000
-69.8%
18,800
+1.1%
0.00%
Q4 2021$43,000
-14.0%
18,600
+70.6%
0.00%
Q3 2021$50,000
-20.6%
10,900
-23.5%
0.00%
Q2 2021$63,000
-74.6%
14,250
-56.1%
0.00%
Q4 2020$248,00032,4300.00%
Other shareholders
LOGICBIO THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Lion Point Capital, LP 500,000$2,220,0000.38%
Orbimed Advisors 8,466,783$37,593,0000.38%
Sio Capital Management, LLC 182,630$811,0000.20%
Tibra Equities Europe Ltd 76,500$340,0000.10%
SAMLYN CAPITAL, LLC 1,420,452$6,308,0000.09%
PURA VIDA INVESTMENTS, LLC 249,256$1,107,0000.03%
Trexquant Investment LP 46,229$205,0000.02%
SANDERS MORRIS HARRIS LLC 15,000$67,0000.01%
Baker Brothers Advisors 451,478$2,005,0000.01%
Verition Fund Management LLC 208,099$924,0000.01%
View complete list of LOGICBIO THERAPEUTICS INC shareholders